People on the Move Archives - Page 66 of 152

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

March 13, 2026

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

THIS WEEK'S STORIES

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

March 10, 2026

InterSystems Taps Health System Veteran Tim Ferris, M.D., to Lead Global Healthcare Strategy

March 9, 2026

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

March 10, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

Aurion Biotech Names Marjan Farid, M.D., Chair of Medical Advisory Board

Cognito Therapeutics Names Thomas Fagan Executive Vice President of Alzheimer’s Portfolio

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

Most Read

KORU Medical Systems Secures EU MDR Certification for Freedom60 Infusion Pump With Prefilled Syringe Compatibility

OpenFold Consortium Releases Major OpenFold3 Update and Public Training Data for Biomolecular AI

Allurion Appeals NYSE Delisting Decision as It Pursues Plan to Regain Listing Compliance

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

EDITOR PICKS

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

THIS WEEK'S STORIES

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

InterSystems Taps Health System Veteran Tim Ferris, M.D., to Lead Global Healthcare Strategy

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US